A b s t r a c t
Viral hepatitis is a major global health problem. 1 The hepatitis C virus (HCV) is 1 of 7 known viruses (hepatitis A, B, C, D, E, G, and TT viruses) that together account for the majority of cases of viral hepatitis. [2] [3] [4] HCV is the most common chronic blood-borne infection in the United States and is considered an epidemic by the Centers for Disease Control and Prevention, Atlanta, GA, with a 4-fold higher prevalence than HIV. 5 More than 4 million people are infected in the United States, and according to the World Health Organization, 170 million people are reported to be infected worldwide. 5 HCV contains a single-stranded RNA molecule with positive polarity that does not undergo reverse transcription into a DNA intermediate during the virus' life cycle. Other positive-strand RNA flaviviruses have been shown to undergo replication via the production of a negative-strand replication intermediate. 5 In HCV-infected cells, RNA molecules with negative polarity (minus strand) representing replication intermediates indicate active replication of the viral genome. 6 Since HCV was first cloned in 1989, substantial progress has been made in characterizing its molecular biology. 7 But the natural history of HCV infection still is largely unclear, and current treatment options for patients are limited. There is no vaccine for HCV, and the only available treatment, a combination of alfa-interferon and ribavirin, is efficacious in only a minority of patients. 8 Chronic infection can lead to liver inflammation, cirrhosis, cancer, and death.
In an earlier work, the expected 100% correlation between the level of HCV viremia and serious liver damage was not experimentally verifiable. 9 The details of HCV proliferation are still unclear owing to the lack of a reliable cell culture model and a sensitive detection method for studying its replication. Consequently, it is critical to develop a cell culture system and a highly sensitive detection method that will permit the study of HCV replication in vitro. To that end, we established an in vitro-infected cell culture system for the replication of HCV by using human T and B leukemia cell lines. The MOLT-4 cell line has been tested previously for its susceptibility to HCV infection. 10 MO-B is an Epstein-Barr virus (EBV)-transformed lymphoblast B-cell line. It is positive for EBV viral capsid antigen and nuclear antigen. We used this cell line because previous research 11 showed that HCV replication is promoted by the EBV in vitro. In the present study, a new method, which involves an enzymatic, hot-start, nested polymerase chain reaction (PCR) in a single closed tube, was developed for sensitive detection of HCV minus-strand RNA at extremely low levels in cell lines. By using this method, we found that T and B lymphocytes may serve as a cellular host for hepatitis C viral propagation. Further understanding of the role of hepatitis C viral replication in peripheral blood mononuclear leukocytes may lead to the ability to control hepatitis C infection.
Materials and Methods

Clinical Specimens
Pooled serum specimens were obtained from patients at the US Department of Veterans Affairs Medical Center, Bronx, NY, who were chronically infected with HCV. Chronic HCV infection was defined by elevated serum alanine aminotransferase and by the presence of anti-HCV antibodies as detected by enzyme-linked immunoassay and confirmed by an immunoblot assay. Plasma HCV viral load was quantified by using the Monitor HCV Assay (Roche Molecular Systems, Branchburg, NJ).
Cell Lines and In Vitro Infection
The principal human leukemia cells lines and culture conditions used in this study were as follows:
1. The human MOLT-4 T-cell acute lymphoblastic leukemia cell line originally was obtained from the American Type Culture Collection (ATCC, Rockville, MD), and was maintained in RPMI 1640 ATCC modified medium (ATCC) supplemented with 5% fetal bovine serum (ATCC) in 75 cm 2 To stimulate the growth of infected cells to increase HCV RNA replication, mitogens were added to initiate cell culture and maintained throughout the experiment. Concanavalin A (2 µg/mL; Sigma, St Louis, MO) and phytohemagglutinin (1 µg/mL; Sigma) were added to the cell culture to activate T lymphocytes, and bacterial lipoprotein lipopolysaccharide (5 µg/mL; Sigma) was added to activate B lymphocytes. The cells were incubated in a 37°C humidified incubator in an atmosphere of 5% to 7% carbon dioxide. The cell viability was monitored by using trypan blue dye. Cell morphologic features were assayed by light microscopy, which revealed well-preserved cellular morphologic features. In vitro infection of B-and T-cell lines was performed by using HCV RNA-positive serum from the chronic HCV carriers already described. The cells then were subcultured regularly, as were the uninfected cell lines. The stability of the viral infection in the cultures was monitored by our novel, highly sensitive method of reverse transcription (RT)-nested PCR. Samples for examination by RT-nested PCR were harvested daily from the infected cell cultures. Cell pellets were tested daily by PCR for the presence of HCV minus-strand RNA.
Extraction of HCV RNA
Total RNA was extracted from infected and noninfected cell lines and from the final cell wash supernatant at different times after infection. Cultured B-and T-cell lines were washed 5 times with phosphate-buffered saline to remove all free, serum-associated virus particles. Total cellular RNA was recovered from cells each day by a single-step extraction method 12, 13 with an acid guanidinium thiocyanate-phenolchloroform mixture (Biotecx Laboratories, Houston, TX). The total RNA remained exclusively in the aqueous phase, while proteins and DNA were extracted into an organic phase and interphase. The total RNA was precipitated from the aqueous phase by addition of an equal volume of 100% isopropanol, washed with 75% ethanol, and solubilized in RNase free water. During RNA extraction, special care was taken to avoid cross-contamination by separating pre-PCR and post-PCR work areas and using plugged tips. In each experiment, negative controls (reagent without RNA) for each test sample were subjected to the RNA extraction procedure, reverse transcription, and amplification in parallel with the test samples. Purified RNA was treated with 0.1 U/µL of DNase I (Sigma) to further remove any DNA carryover from samples. An HCV-positive control RNA was prepared by extracting RNA from pooled serum samples of patients chronically infected with HCV.
Oligonucleotide Primers
The entire genome of HCV has been sequenced and is now well characterized. [14] [15] [16] [17] It is a positive-strand RNA virus with a genome length of 9,600 nucleotides. The 5' untranslated region (Gen-Bank accession No. M58406) of the HCV is a remarkably well-conserved region among different HCV isolates and has provided excellent sites 18 for oligonucleotide primers that were synthesized (Operon Technologies, Alameda, CA), based on this region's sequence ❚Table 1❚.
Preparation of Strand-Specific HCV Complementary DNA
After total RNA was recovered each day, the minusstrand RNA was detected by an enhanced detection system using recombinant Thermus thermophilus DNA polymerase (rTth) RT-PCR (Perkin Elmer/Applied Biosystems, Foster City, CA), which is easier to perform and yields better strand specificity than the classic reverse-transcribed method. With thermostable rTth 19 RT-PCR, false priming of the incorrect strand was avoided by conducting complementary DNA (cDNA) synthesis at 70°C. cDNA synthesis was performed by using a sense oligonucleotide primer instead of an antisense primer. Reactions were performed with 2 µL of 10× reverse transcriptase buffer; 2 µL of a 10-mmol/L concentration of magnesium chloride; 200-µmol/L concentrations each of deoxyadenosine triphosphate, deoxycytidine triphosphate, deoxyguanosine triphosphate; a 100-µmol/L concentration of deoxythymidine triphosphate (dTTP); 0.2 U of uracil-N-glycosylase (UNG; Perkin Elmer/Applied Biosystems) 20 ; 5 U of rTth DNA polymerase; and 50 pmol of upstream HCV primer and template RNA. The RT mixture was incubated first for 10 minutes at room temperature and then 70°C for 15 minutes.
5' Untranslated Region Amplification by Single-Tube Nested PCR
After a portion of the 5' untranslated region of the minus-strand RNA was reverse transcribed, the cDNA product was detected by nested PCR. The cDNA product was subjected to the first PCR with 80 µL of PCR reaction solution containing 50 pmol of HCV downstream primer, 8 µL of 10× chelating buffer, 8 µL of a 25-mmol/L concentration of magnesium chloride, 200 µmol/L of deoxyuridine triphosphate (dUTP), and 0.8 U of UNG. For the second PCR, 50 pmol each of the inner UNG-treated HCV primers were injected onto the surface of heavy mineral oil (Fisher Scientific, Springfield, NJ). Before the PCR test, the PCR mixture was incubated for 10 minutes at room temperature to permit the UNG to excise dUTP-containing PCR products from any previous amplification or contaminating source and then incubated for 10 minutes at 95°C to inactivate UNG. Both rounds consisted of 35 cycles of PCR in a DNA Thermal Cycler 480 (Perkin Elmer/Applied Biosystems). Each cycle consisted of denaturation at 94°C for 1 minute and combined annealing and extension at 68°C for 2 minutes. After the first 35 cycles, the tubes were centrifuged for 1 minute to mix the second PCR mixture with the first one. After the second 35 cycles, 10 µL of the nested PCR product was analyzed by electrophoresis on 2% NuSieve GTG agarose gel (FMC Bioproducts, Rockland, ME) in a 1× Tris-boric acid-ethylenediamine tetraacetic acid buffer, stained with ethidium bromide, and then visualized under UV light transillumination (Bio-Rad Laboratories, Hercules, CA). The PCR-amplified products were differentiated by fragment size ❚Image 1❚, with the nested PCR product being 255 base pairs (bp).
Self-Priming Detection
To detect false, random, and self-priming, extracted HCV RNA was run in duplicate in every RT-PCR test without addition of an upstream HCV primer. 21 The rTth method was used for the detection of both strands.
Fluorescent DNA Sequencing of the HCV PCR Product
Specific nested PCR products generated from the minusstrand RNA obtained from HCV-infected cell lines were sequenced directly by using ABI Prism BigDye Terminator Cycle Sequencing Ready Reaction Kits and the ABI Prism 310 Genetic Analyzer (Perkin Elmer/Applied Biosystems) according to the manufacturer's instructions. Nested PCR products were purified on Microcon purification columns (Millipore, Bedford, MA). Ten nanograms of purified nested-PCR product was subjected to a cycle-sequencing reaction with 3.2 pmol of an unlabeled HCV nested primer and terminator reaction mix. The cycle-sequencing reaction consisted of 25 cycles in a DNA Thermal Cycler 9700 (Perkin Elmer/Applied Biosystems), and each cycle consisted of denaturation at 96°C for 10 seconds, annealing at 50°C for 5 seconds, and extension at 60°C for 4 minutes. After 25 cycles, the fluorescent extension products were purified by a simple isopropanol precipitation step. DNA sequence data were analyzed by the Chromas program (Helensvale, Queensland, Australia), GenBank sequence database, 22 and Blast program from the National Center for Biotechnology Information. 23, 24 Results
A Novel, Single-Tube Nested PCR Strategy
Nested PCR is a highly sensitive 2-step procedure 18 in which the products of a first PCR using "outer" primers are reamplified using a second set of "inner" primers located within the previously amplified sequence. Reliable nested PCR without carryover or contamination is difficult to achieve. The PCR product from the first amplification step of the nested PCR generally is responsible for the contamination. We developed a variant technique in which both reactions were carried out sequentially in the same tube. The outer and inner PCR primers yielded 2 expected products of 271 and 255 bp. This reamplified 255-bp product indicated that HCV replication via a minus-strand RNA intermediate was occurring in the cell lines (Image 1).
HCV RNA replication was detected in the cell lines in the present study. Minus-strand RNA of HCV was detected by our rTth-based single tube RT-PCR test, which was optimized for sensitivity and strand specificity on synthetic RNA templates. HCV minus-strand RNA was detected in an HCVinfected T-cell line in 28 of 34 consecutive daily samples and in 31 of 34 consecutive daily samples with the HCV-infected B-cell line. This result clearly and reliably identifies the replication of HCV in the T-and B-cell line models. There was no significant difference in the ability to detect HCV intracellular minus-strand RNA in the 2 cell lines ❚Table 2❚. These cell lines might prove to be useful tools for studying HCV replication in vitro. Control experiments showed that detection of minus-strand HCV RNA was more difficult than plus-strand RNA (data not shown). Only high-sensitivity nested amplification can detect the minus-strand HCV RNA, which is present in extremely low levels inside the cells. Also, this technique verified the specificity of the first-round PCR product in much the same way as a labeled probe does.
No false priming was found. The possibility of false, random, and self-priming was carefully evaluated. With rTth RT, false priming of the incorrect strand was avoided by conducting cDNA synthesis at 70°C. To determine whether false priming occurred, potentially self-priming control samples without the addition of an upstream primer were carried through every reaction and were consistently negative (Image 1, lane 4). Under these conditions, no significant selfpriming was found.
Efficient use of UNG prevents carryover contamination. A method that involves an enzymatic hot-start nested PCR in a single closed tube was developed for the sensitive detection of HCV in the present study. Single-tube nested PCR, together with the use of UNG and dUTP instead of dTTP, prevented false-positive results caused by carryover of the products from previous amplification reactions. While retaining high sensitivity of the conventional nested PCR, our 1-tube nested PCR with UNG anticontamination technology greatly reduced the risk of carryover contamination.
Specificity of the PCR products was characterized further by direct DNA sequencing. For further characterization of the PCR product, nested PCR products generated from minus-strand RNA from cell lines were sequenced directly. The sequences were determined to be within the 5' untranslated region. The results of the direct DNA sequencing and classic Southern blot hybridization (data not shown) of the resulting amplicons were concordant in our study. We found that direct sequencing using fluorescent dye-labeled oligonucleotides substantially reduced the time and labor required compared with Southern blot analysis and can dramatically improve characterization of the PCR product.
Discussion
HCV has been identified as a causative agent in most cases of posttransfusion hepatitis in the United States. Therefore, understanding HCV replication and propagating the virus in laboratory cultures is urgently needed. It is unclear whether lymphocytes, especially B lymphocytes, could be a site for HCV replication. As with other Flaviviridae, HCV replicates according to a direct RNA-RNA mechanism, without any intermediate passage through a DNA stage and without genomic integration. Because minus-strand RNA is considered a replication intermediate of the viral genome, detection of HCV minus-strand RNA would be a means to confirm HCV replication in cell lines. Many previous studies have demonstrated HCV infection and replication in human primary hepatic cell lines, 17, 25, 26 chimpanzee hepatic cell lines, 27, 28 and human lymphocyte cell lines. 10, [29] [30] [31] However, these systems have poor reproducibility and a low level of HCV replication. 32 The lack of highly sensitive techniques to detect HCV replication has been one of the major problems in the field of HCV research. To address this need, we established a reliable cell culture system and developed a detection method with sufficient sensitivity for testing HCV replication. With rTth RT, false priming of the incorrect strand was avoided by conducting cDNA synthesis at 70°C, which greatly improved strand-specific detection of HCV minusstrand RNA. We also used UNG and dUTP instead of dTTP to prevent false-positive results caused by carryover of the products from previous amplification reactions. The UNG method used in the present study provided the enzymatic equivalent of a hot start to degrade any nonspecific extension of the PCR products.
Because the initial amount of amplification product is not sufficient for detection, a second-round (nested) PCR was required. The nested primers have a sequence complementary to sequences within the amplified target of the first PCR. This modification of the PCR procedure in combination with direct DNA sequencing was specific enough to detect minus-strand RNA from cell culture. This is a novel approach to detect HCV minus-strand RNA, and is more sensitive than other PCR techniques used for this purpose. 33 We believe that rTth-RT nested PCR plus UNG offers a useful method for detecting HCV replication via its minusstrand RNA at extremely low levels.
The results of our study demonstrate that HCV can infect B-and T-lymphocyte cell lines in vitro, and HCV minus-strand RNA can be detected in lymphocytes using reverse transcription and subsequent amplification of the cDNA by PCR. We successfully used human leukemia cell lines, MOLT-4 and MO-B, to replace the classic chimpanzee model to study HCV replication. Taking advantage of these cell lines, which we showed can be stably infected with HCV for at least 39 days, should make studying HCV replication more feasible. Thus, our results support the hypothesis that HCV can replicate in peripheral blood mononuclear cells. We are one of few groups who have shown HCV replication in the B-cell line. Consequently, in conjunction with the 1-tube, nested PCR technique, the MOLT-4 and MO-B cell lines can be further used for the continuous production of HCV to analyze its replication and for other biologic studies. 
